MENU
+Compare
IGC
Stock ticker: ASE
AS OF
Apr 3, 04:55 PM (EDT)
Price
$0.28
Change
-$0.00 (-0.00%)
Capitalization
22.5M

IGC IGC Pharma Forecast, Technical & Fundamental Analysis

IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer’s disease, period cramps, premenstrual syndrome and chronic pain... Show more

Industry: #Biotechnology
IGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for IGC with price predictions
Apr 02, 2025

IGC sees MACD Histogram just turned negative

IGC saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on March 26, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 55 instances where the indicator turned negative. In of the 55 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 24, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on IGC as a result. In of 106 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

IGC moved below its 50-day moving average on March 24, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for IGC crossed bearishly below the 50-day moving average on March 28, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 23 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IGC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

IGC broke above its upper Bollinger Band on March 12, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for IGC entered a downward trend on March 06, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where IGC's RSI Indicator exited the oversold zone, of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IGC advanced for three days, in of 221 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.596) is normal, around the industry mean (13.260). P/E Ratio (0.000) is within average values for comparable stocks, (64.931). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.878). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (16.611) is also within normal values, averaging (252.036).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. IGC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IGC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
IGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

IGC is expected to report earnings to -1 cents per share on June 18

IGC Pharma IGC Stock Earnings Reports
Q1'25
Est.
$-0.02
Q4'24
Beat
by $0.01
Q3'24
Beat
by $0.01
Q2'24
Beat
by $0.01
Q1'24
Est.
$-0.04
The last earnings report on February 18 showed earnings per share of -1 cents, beating the estimate of -2 cents. With 98.39K shares outstanding, the current market capitalization sits at 22.50M.
A.I. Advisor
published General Information

General Information

a company, which engages in focuses on developing and commercializing a portfolio of cannabinoid based biopharmaceutical therapies

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
10224 Falls Road
Phone
+1 301 983-0998
Employees
61
Web
https://www.igcinc.us
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PERI8.490.26
+3.16%
Perion Network Ltd
ICLR168.702.14
+1.28%
ICON plc
GRFX1.10N/A
N/A
Graphex Group Limited
PCYO10.53-0.15
-1.40%
Pure Cycle Corp
CBZ75.32-1.66
-2.16%
CBIZ

IGC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IGC has been loosely correlated with TECX. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if IGC jumps, then TECX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IGC
1D Price
Change %
IGC100%
-1.12%
TECX - IGC
36%
Loosely correlated
+6.24%
ANVS - IGC
30%
Poorly correlated
+6.71%
AMLX - IGC
30%
Poorly correlated
+13.17%
LRMR - IGC
27%
Poorly correlated
+10.00%
VTGN - IGC
27%
Poorly correlated
+2.14%
More